Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
secondary literature

Data source

Reference
Reference Type:
secondary source
Title:
Methylprednisolone, Summary Report
Author:
The European Agency for the Evaluation of Medicinal Products, Committee for Veterinary Medicinal Products
Year:
2001
Report date:
2001

Materials and methods

Limit test:
no

Test material

Constituent 1
Reference substance name:
86401-95-8
Cas Number:
86401-95-8
IUPAC Name:
86401-95-8
Constituent 2
Reference substance name:
Methylprednisolone aceponate
IUPAC Name:
Methylprednisolone aceponate
Constituent 3
Reference substance name:
11β,17,21-Trihydroxy-6α-methylpregna-1,4-diene-3,20-dione, 21-acetate 17-propionate
IUPAC Name:
11β,17,21-Trihydroxy-6α-methylpregna-1,4-diene-3,20-dione, 21-acetate 17-propionate

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female

Administration / exposure

Route of administration:
subcutaneous
Doses:
0-3000 mg/kg bw
Control animals:
not specified

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 3 000 mg/kg bw
Based on:
test mat.

Applicant's summary and conclusion

Conclusions:
When the test substance was administered to rats subcutaneously, the LD50 value was greater than 3000 mg/kg bw, the highest dose administered.